Filing Flows › Harmony Biosciences Holdings (HRMY) › Net income
Harmony Biosciences Holdings (HRMY) net income by quarter
Harmony Biosciences Holdings' net income was $48.2M in Q3 2026 (third quarter 2026), -36% from Q2 2026. Over the last 7 quarters it ranged from $22.5M (Q4 2025) to $75.4M (Q2 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $48.2M | -36% | -5% |
| Q2 2026 | $75.4M | +132% | +90% |
| Q1 2026 | $32.5M | +44% | -29% |
| Q4 2025 | $22.5M | -56% | — |
| Q3 2025 | $50.9M | +28% | — |
| Q2 2025 | $39.8M | -13% | — |
| Q1 2025 | $45.6M | — | — |
Q3 2026 at a glance
Harmony Biosciences Holdings, Q3 2026: revenue $269M (+12% year over year), operating margin 20.2%, net earnings $48.2M, operating cash flow $76.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Harmony Biosciences Holdings' net income?
Harmony Biosciences Holdings' net income was $48.2M in Q3 2026 (third quarter 2026), -36% from Q2 2026.
How has Harmony Biosciences Holdings' net income changed?
Over the last 7 quarters it ranged from $22.5M (Q4 2025) to $75.4M (Q2 2026).
Q3 2026 results → · How Harmony Biosciences Holdings makes money →